Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
19.01
+0.12 (0.64%)
At close: Jul 21, 2026, 4:00 PM EDT
19.01
0.00 (0.00%)
After-hours: Jul 21, 2026, 4:10 PM EDT

IART Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, IART stock has a consensus rating of "Hold" and an average price target of $18. The average 1-year stock price forecast is 5.31% lower than the current stock price, while the lowest is $11 (-42.14%) and the highest is $27 (+42.03%).

Price Target: $18 (-5.31%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$11$18$17$27
Change-42.14%-5.31%-10.57%+42.03%

Analyst Ratings

The average analyst rating for IART stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy221122
Buy111111
Hold444656
Sell221222
Strong Sell211000
Total11108101011

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Truist Financial
Truist Financial
Hold
Maintains
$14$19
HoldMaintains$14$19-0.05%Jul 16, 2026
BMO Capital
BMO Capital
Hold
Initiates
$19
HoldInitiates$19-0.05%Jul 8, 2026
Citi
Citi
Hold
Maintains
$16$19
HoldMaintains$16$19-0.05%Jul 8, 2026
BTIG
BTIG
Hold
Maintains
n/a
HoldMaintainsn/an/aJun 23, 2026
Argus Research
Argus Research
Buy
Upgrades
$25
BuyUpgrades$25+31.51%Jun 18, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.68B
from 1.64B
Increased by 2.50%
Revenue Next Year
1.73B
from 1.68B
Increased by 3.22%
EPS This Year
2.45
from 2.23
Increased by 9.86%
EPS Next Year
2.62
from 2.45
Increased by 6.86%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.54B1.56B1.54B1.61B1.64B1.68B
Revenue Growth
12.43%0.99%-1.03%4.47%1.54%2.50%
Gross Profit
944.64M970.31M884.74M959.12M919.42M1.05B
Gross Margin
61.24%62.29%57.39%59.55%56.23%62.50%
Operating Income
199.98M238.92M111.53M181.98M145.92M291.10M
Net Income
169.08M180.55M67.74M-6.94M-516.47M42.73M
EPS
----2.232.45
EPS Growth
-----12.89%9.86%
Forward PE
20.1916.1612.948.835.217.76
Free Cash Flow
377.40M165.64M84.87M90.15M44.46M204.23M
No. Analysts
-----11
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High1.7B
Avg1.7B
Low1.7B

Revenue Growth

Revenue Growth202620272028
High
3.1%
Avg
2.5%
Low
1.6%

EPS Forecast

EPS202620272028
High2.50
Avg2.45
Low2.42

EPS Growth

EPS Growth202620272028
High
12.1%
Avg
9.9%
Low
8.4%